| 英文名称 | 中文名称 | CAS | MF |
|
Cyclopentaneacetic acid, -alpha--acetyl-3-oxo-, methyl ester, (1S)- (9CI)
|
|
646038-06-4
|
C10H14O4
|
|
Quinoline, 3,4-dihydro-6-methoxy-2-methyl- (9CI)
|
|
646039-18-1
|
C11H13NO
|
|
1-(2-AMinoethyl)-4-Methylpiperazine Hydrochloride
|
1-(2-氨乙基)-4-甲基哌嗪盐酸盐
|
646051-17-4
|
C7H18ClN3
|
|
Benzaldehyde, 2-fluoro-, O-methyloxime, [C(E)]- (9CI)
|
|
646051-22-1
|
C8H8FNO
|
|
Bis(4-fluorobenzyl)aMine
|
皮马万塞林杂质
|
646051-52-7
|
C14H13F2N
|
|
Cyclopropanesulfonamide, 1-phenyl- (9CI)
|
Cyclopropanesulfonamide, 1-phenyl- (9CI)
|
646051-96-9
|
C9H11NO2S
|
|
4-Morpholineethanamine,N-methylene-(9CI)
|
|
646051-97-0
|
C7H14N2O
|
|
1,3-Isobenzofurandione,4-ethynyl-(9CI)
|
4-乙炔基异苯并呋喃-1,3-二酮
|
646052-77-9
|
C10H4O3
|
|
3-Pyridinesulfonamide,2-amino-6-methyl-(9CI)
|
|
646053-55-6
|
C6H9N3O2S
|
|
2H-Pyrido[2,3-e]-1,2,4-thiadiazine, 3,6-dimethyl-, 1,1-dioxide (9CI)
|
|
646053-57-8
|
C8H9N3O2S
|
|
Repaglinide IMpurity IV
|
瑞格列奈杂质IV
|
646054-50-4
|
C23H37N3O
|
|
1-Fluoro-4-(4-nitrophenyl)-2-(trifluoroMethyl)benzene
|
1-FLUORO-4-(4-NITROPHENYL)-2-(TRIFLUOROMETHYL)BENZENE
|
646054-51-5
|
C13H7F4NO2
|
|
1-benzyl-1,7-diazaspiro[4.4]nonan-6-one
|
|
646055-59-6
|
C14H18N2O
|
|
1-Benzyl-1,7-diaza-spiro[4.4]nonane-7-carboxylic acid tert-butyl ester
|
1-苄基-1,7-二氮杂螺[4.4]壬烷-7-羧酸叔丁酯
|
646055-62-1
|
C19H28N2O2
|
|
7-Boc-1,7-diaza-spiro[4.4]nonane
|
2,6-二氮杂螺[4.4]壬烷-2-羧酸叔丁酯
|
646055-63-2
|
C12H22N2O2
|
|
1'-(3-PYRIDINYL)-SPIRO[1-AZABICYCLO[2.2.1]HEPTANE-2,3'-PYRROLIDINE]DIHYDROCHLORIDE
|
|
646055-75-6
|
C14H21Cl2N3
|
|
1-Azabicyclo[2.2.1]heptane-2-carboxylicacid,ethylester(9CI)
|
(1R,4R) - 1-氮杂双环[2.2.1]庚烷-2-羧酸乙酯
|
646055-79-0
|
C9H15NO2
|
|
ETHYL 2-(2-NITROETHYL)-1-AZABICYCLO[2.2.1]HEPTANE-2-CARBOXYLATE
|
|
646055-80-3
|
C11H18N2O4
|
|
Spiro[1-azabicyclo[2.2.1]heptane-2,3-pyrrolidin]-2-one (9CI)
|
|
646055-81-4
|
C9H14N2O
|
|
Spiro[1-azabicyclo[2.2.1]heptane-2,3-pyrrolidine] (9CI)
|
|
646055-82-5
|
C9H16N2
|
|
Spiro[1-azabicyclo[2.2.2]octane-2,3-pyrrolidine] (9CI)
|
|
646055-90-5
|
C10H18N2
|
|
ethyl 2-aMino-2-(tetrahydro-2H-pyran-4-yl)acetate
|
2-氨基-2-(四氢-2H-吡喃-4-基)乙酸 乙酯
|
646055-93-8
|
C9H17NO3
|
|
1-Azabicyclo[2.2.1]heptane-7-carboxylic acid, hydrochloride
|
1-氮杂双环[2,2,1]庚烷-7-羧酸盐酸盐
|
646055-94-9
|
C7H12ClNO2
|
|
1-Azabicyclo[2.2.1]heptane-7-carboxylicacid,ethylester(9CI)
|
|
646055-95-0
|
C9H15NO2
|
|
Spiro[1-azabicyclo[2.2.1]heptane-7,3-pyrrolidin]-2-one (9CI)
|
|
646055-97-2
|
C9H14N2O
|
|
Spiro[1-azabicyclo[2.2.1]heptane-7,3-pyrrolidine] (9CI)
|
|
646055-98-3
|
C9H16N2
|
|
1,2-Acenaphthylenedione,4-amino-(9CI)
|
|
646058-51-7
|
C12H7NO2
|
|
Pentitol, 3,4-anhydro-1,2-dideoxy-2,2-dimethyl- (9CI)
|
|
646058-57-3
|
C7H14O2
|
|
Carbamic acid, [(4E)-6-oxo-4-hexenyl]-, 1,1-dimethylethyl ester (9CI)
|
|
646062-88-6
|
C11H19NO3
|
|
XLI 093
|
XLI 093
|
646066-59-3
|
C33H26N6O6
|
|
3,4,5-Trifluoro-L-phenylalanine
|
L-3,4,5-三氟苯丙氨酸
|
646066-73-1
|
C9H8F3NO2
|
|
2-Azetidinone,3,4-diethyl-1-(phenylmethyl)-,(3R,4S)-(9CI)
|
|
646067-36-9
|
C14H19NO
|
|
9,10-Phenanthrenediol, 1,2,3,4,4a,9,10,10a-octahydro- (9CI)
|
|
646068-56-6
|
C14H18O2
|
|
FMOC-β-homocys(trt)-oh
|
FMOC-β-homocys(trt)-oh
|
646068-80-6
|
C38H33NO4S
|
|
Hydrazinecarboxylic acid, 2-cyclopentyl-, 1,1-dimethylethyl ester (9CI)
|
Hydrazinecarboxylic acid, 2-cyclopentyl-, 1,1-dimethylethyl ester (9CI)
|
646071-31-0
|
C10H20N2O2
|
|
tert-butyl 4-(carbamoylamino)piperidine-1-carboxylate
|
叔-丁基 4-脲基哌啶-1-甲酸基酯
|
646071-42-3
|
C11H21N3O3
|
|
[3-(MORPHOLIN-4-YLSULFONYL)PHENYL]METHANOL
|
3-(吗啉-4-磺酰基)苯基]甲醇
|
646071-55-8
|
C11H15NO4S
|
|
2-Propenamide, 2-(acetylamino)-N,N-diethyl-
|
|
646072-00-6
|
C9H16N2O2
|
|
1-[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]-1,4-DIAZEPANE
|
1-[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]-1,4-DIAZEPANE
|
646455-48-3
|
C12H14F3N3O2
|
|
1-(4-BROMO-2-FLUOROBENZYL)-1,4-DIAZEPANE
|
1-(4-溴-2-氟苄基)-1,4-二氮杂卓
|
646455-62-1
|
C12H16BrFN2
|
|
2-[(2-BROMO-4-CHLORO-6-METHYLPHENOXY)METHYL]OXIRANE
|
|
646455-78-9
|
C10H10BrClO2
|
|
3-BROMO-1-(4-[5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]-1,4-DIAZEPAN-1-YL)PROPAN-1-ONE
|
|
646455-90-5
|
C14H17BrF3N3O
|
|
1-(4-METHOXYPHENOXY)-3-[4-(2-METHOXYPHENYL)PIPERIDINO]PROPAN-2-OL
|
|
646455-96-1
|
C22H29NO4
|
|
(4-[2-HYDROXY-3-(4-METHOXYPHENOXY)PROPYL]-1,4-DIAZEPAN-1-YL)(2-THIENYL)METHANONE
|
(4-(2-羟基-3-(4-苯氧基甲氧基)丙基)-1,4-二氮杂环庚烷-1-基)(噻吩-2-基)甲酮
|
646455-98-3
|
C20H26N2O4S
|
|
1-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]-4-{[4-(pent-1-yl)phenyl]sulphonyl}homopiperazine, 3-Chloro-2-(4-{[4-(pent-1-yl)phenyl]sulphonyl}-1,4-diazepan-1-yl)-5-(trifluoromethyl)py
|
|
646456-06-6
|
C22H27ClF3N3O2S
|
|
1-(2-[1,1'-BIPHENYL]-4-YL-2-OXOETHYL)-4-[2-(1H-INDOL-3-YL)ETHYL]PYRIDINIUM BROMIDE
|
|
646456-30-6
|
C29H25BrN2O
|
|
Etoricoxib Impurity 7
|
依托考昔杂质 7
|
646459-39-4
|
C20H21N3O2S
|
|
Etoricoxib Impurity 12
|
依托考昔杂质 12
|
646459-41-8
|
C21H16ClN3O2S
|
|
8-Methyl-8-azabicyclo[3.2.1]octan-3-amine dihydrochloride
|
8-甲基-8-氮杂双环[3,2,1]辛-3-胺盐酸盐
|
646477-45-4
|
C8H17ClN2
|
|
4-hydroxy-5-Methyl-5-octylthiophen-2(5H)-one
|
|
646483-08-1
|
C13H22O2S
|
|
3-Amino-3,4-dihydro-4-oxo-2-{[(tetrahydrofur-2-yl)methyl]carbamoyl}quinazoline, 2-({[(3-Amino-3,4-dihydro-4-oxoquinazolin-2-yl)carbonyl]amino}methyl)furan
|
3-氨基-4-氧代-N-((3-((4-氧代-2-(((四氢呋喃-2-基)甲基)氨基甲酰基)喹唑啉-3(4H)-基)氨基)呋喃-2-基)甲基)-3,4-二氢喹唑啉-2-甲酰胺
|
646497-34-9
|
C14H16N4O3
|
|
VcMMAE
|
单甲基奥瑞他汀E
|
646502-53-6
|
C68H105N11O15
|
|
2-FLUOROBENZOIC-D4 ACID
|
2-FLUOROBENZOIC-D4 ACID
|
646502-89-8
|
C7HD4FO2
|
|
Quinoxaline, 6-chloro-7-methyl-
|
6-CHLORO-7-METHYLQUINOXALINE
|
646504-79-2
|
C9H7ClN2
|
|
6-Bromo-7-methylquinoxaline
|
6-溴-7-甲基喹喔啉
|
646504-80-5
|
C9H7BrN2
|
|
Quinoxaline, 2-amino-6-methyl- (5CI)
|
|
646504-83-8
|
C9H9N3
|
|
2(5H)-Furanone, 4-methyl-5-(2-propenyloxy)- (9CI)
|
|
646504-94-1
|
C8H10O3
|
|
1,2-Anthracenediol, 1,2,9,10-tetrahydro-, (1R,2S)- (9CI)
|
|
646505-35-3
|
C14H14O2
|
|
1H-Fluorene-1,2,9-triol, 2,9-dihydro-, (1R,2S,9R)- (9CI)
|
|
646505-37-5
|
C13H12O3
|
|
1H-Pyrazol-3-amine,N,1,5-trimethyl-(9CI)
|
N,1,5-三甲基-1H-吡唑-3-胺
|
646506-40-3
|
C6H11N3
|
|
N-(1,1-DIMETHYLPROP-2-YNYL)-N'-(2,2,2-TRICHLORO-1-HYDROXYETHYL)UREA
|
|
646506-48-1
|
C8H11Cl3N2O2
|
|
2,3-DIBROMO-1-(2,3,4,5,6-PENTAMETHYLPHENYL)-3-PHENYLPROPAN-1-ONE
|
|
646506-57-2
|
C20H22Br2O
|
|
3-(3-AMINOPHENYL)-1-(2,3,4,5,6-PENTAMETHYLPHENYL)PROPAN-1-ONE
|
|
646506-64-1
|
C20H25NO
|
|
3H-Fluorene-3,4,9-triol, 4,9-dihydro-, (3S,4R,9S)- (9CI)
|
|
646507-12-2
|
C13H12O3
|
|
3H-Fluorene-3,4,9-triol, 4,9-dihydro-, (3S,4R,9R)- (9CI)
|
|
646507-14-4
|
C13H12O3
|
|
1H-Fluorene-1,2,9-triol, 2,9-dihydro-, (1R,2S,9S)- (9CI)
|
|
646507-15-5
|
C13H12O3
|
|
1H-Inden-1-ol,5-methoxy-2-methyl-(9CI)
|
|
646507-51-9
|
C11H12O2
|
|
1H-Inden-1-ol,6-methoxy-2-methyl-(9CI)
|
|
646507-52-0
|
C11H12O2
|
|
1H-Indene,1,5-dimethoxy-2-methyl-(9CI)
|
|
646507-59-7
|
C12H14O2
|
|
Acetamide, N-[(1E)-1-hydroxy-3-oxo-1-butenyl]- (9CI)
|
|
646516-88-3
|
C6H9NO3
|
|
Cyclopentanecarboxylic acid, 2-amino-3-methyl-, 1,1-dimethylethyl ester,
|
|
646518-10-7
|
C11H21NO2
|
|
Cyclopentanecarboxylic acid, 2-amino-3-methyl-, 1,1-dimethylethyl ester,
|
|
646518-16-3
|
C11H21NO2
|
|
Racemic-(4R,4aR,8aS)-ethyl decahydroisoquinoline-4-carboxylate acetate
|
646518-35-6
|
646518-35-6
|
C14H25NO4
|
|
2-Pyridinemethanol,alpha-(bromomethyl)-5-ethyl-(9CI)
|
646519-81-5
|
646519-81-5
|
C9H12BrNO
|
|
Pyridine, 5-ethyl-2-(2-oxido-1,3,2-dioxathiolan-4-yl)- (9CI)
|
646519-82-6
|
646519-82-6
|
C9H11NO3S
|
|
1-(5-Ethylpyridin-2-yl)ethane-1,2-diol
|
1-(5-乙基-2-吡啶基)-1,2-乙二醇
|
646519-83-7
|
C9H13NO2
|
|
2-Hydroxy Pioglitazone Hydrochloride
|
|
646519-87-1
|
C19H21ClN2O4S
|
|
1,2-Benzenediol, 4-[4-[(1-methylethyl)amino]butyl]- (9CI)
|
|
646520-31-2
|
C13H21NO2
|
|
SPIRO[BENZOFURAN-2(3H),1'-CYCLOPENTAN]-3-ONE
|
|
646522-89-6
|
C12H12O2
|
|
Ethanone, 2-cyclopropyl-1-(2-methoxyphenyl)- (9CI)
|
|
646522-92-1
|
C12H14O2
|
|
2-Piperazinecarboxamide,N-propyl-(9CI)
|
|
646523-34-4
|
C8H17N3O
|
|
Methyl (2S)-2-(4-oxo-1,2,3-benzotriazin-3(4H)-yl)-propanoate
|
(2S)-2-(4-氧代-1,2,3-苯并三嗪-3-基)丙酸甲酯
|
646524-72-3
|
C11H11N3O3
|
|
2,4-Dichloro-N-methoxy-N-methylbenzamide
|
|
646528-36-1
|
C9H9Cl2NO2
|
|
Benzoic acid, 4-[[(5-methyl-3-isoxazolyl)carbonyl]amino]- (9CI)
|
|
646530-39-4
|
C12H10N2O4
|
|
2,5-Methano-2H-furo[3,2-b]pyrrol-6-ol, hexahydro-4-methyl-, (2R,3aS,5R,6R,6aR)-rel-(-)- (9CI)
|
|
646530-82-7
|
C8H13NO2
|
|
Pyrimidine, 5-(2-methylphenyl)- (9CI)
|
|
646534-34-1
|
C11H10N2
|
|
Isoxazole, 4-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)- (9CI)
|
|
646534-55-6
|
C8H10N2O2
|
|
GW-300
|
|
646989-21-1
|
C33H40ClN3O4
|
|
1-CHLORO-5-METHOXY-4-NITRO-2-(TRIFLUOROMETHYL)BENZENE
|
2-氯-4-甲氧基-5-硝基三氟甲苯
|
646989-36-8
|
C8H5ClF3NO3
|
|
1H-Pyrrole,1-(1,1-dimethyl-2-propynyl)-(9CI)
|
1-(2-甲基丁-3-炔-2-基)-1H-吡咯
|
646989-37-9
|
C9H11N
|
|
5-(CHLOROMETHYL)-3-[3,5-DI(TRIFLUOROMETHYL)STYRYL]-1,2,4-OXADIAZOLE
|
|
646989-58-4
|
C13H7ClF6N2O
|
|
N1-(4-BROMO-2,6-DIFLUOROPHENYL)-2-CHLOROACETAMIDE
|
N-(4-溴-2,6-二氟-苯基)-2-氯-乙酰胺
|
646989-59-5
|
C8H5BrClF2NO
|
|
2-[(2-CHLORO-6-FLUOROBENZYL)THIO]ANILINE
|
2-[硫代(2-氯-6-氟苯基)]苯胺
|
646989-63-1
|
C13H11ClFNS
|
|
2-FLUORO-6-PIPERIDINOBENZONITRILE
|
2-氟-6-(哌啶-1-基)苯甲腈
|
646989-68-6
|
C12H13FN2
|
|
Formamide, N-(2-cyano-3-fluorophenyl)- (9CI)
|
|
646989-70-0
|
C8H5FN2O
|
|
Benzamide, N-(2,4-dioxo-3-thiazolidinyl)-4-fluoro- (9CI)
|
|
646990-01-4
|
C10H7FN2O3S
|
|
2-[(3-chlorophenoxy)methyl]-5-[4-(3-chlorophenyl)-1-piperazinyl]-1,3-oxazole-4-carbonitrile
|
|
646993-04-6
|
C21H18Cl2N4O2
|
|
2-[(3-chlorophenoxy)methyl]-5-[4-(4-methoxyphenyl)piperazin-1-yl]-1,3-oxazole-4-carbonitrile
|
|
646994-83-4
|
C22H21ClN4O3
|
|
BAY 58-2667 hydrochloride
|
646995-35-9
|
646995-35-9
|
C36H40ClNO5
|
|
2H-Indol-2-one, 3-amino-1,3-dihydro-3-methyl-
|
|
646995-91-7
|
C9H10N2O
|